Breaking News Instant updates and real-time market news.

VKTX

Viking Therapeutics

$11.15

0.91 (8.89%)

, MDGL

Madrigal Pharmaceuticals

$313.25

31.25 (11.08%)

07:44
06/14/18
06/14
07:44
06/14/18
07:44

H.C. Wainwright says don't forget about Viking with Madrigal in play

After Bloomberg reported that Madrigal Pharmaceuticals (MDGL) is exploring a sale after receiving takeover interest, H.C. Wainwright analyst Joseph Pantginis tells investors to not forget about Viking Therapeutics (VKTX). The latter's potential treatment for non-alcoholic steatohepatitis, VK2809, could be even better than Madrigal's, Pantginis contends. The analyst believes that with Madrigal in play, it continues to bring "deserved focus to VK2809, which should garner significant business development interest as well." The analyst thinks VK2809 is "just starting to realize its underlying value from an investment standpoint." Citing the market potential for VK2809 and VK5211, the analyst highlights the value disconnect when comparing Madrigal's market capitalization of $4.8B with Viking's at $652M. Pantginis keeps a Buy rating on Viking Therapeutics with a $15 price target.

VKTX

Viking Therapeutics

$11.15

0.91 (8.89%)

MDGL

Madrigal Pharmaceuticals

$313.25

31.25 (11.08%)

VKTX Viking Therapeutics
$11.15

0.91 (8.89%)

06/01/18
HCWC
06/01/18
NO CHANGE
Target $15
HCWC
Buy
Viking Therapeutics price target raised to $15 from $11 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Viking Therapeutics (VKTX) to $15 saying the data yesterday from Madrigal Pharmaceuticals (MDGL) validate the thyroid receptor beta approach and derisks the VK2809 Phase 2 outcome. The analyst keeps a Buy rating on shares of Viking Therapeutics.
06/01/18
MAXM
06/01/18
NO CHANGE
Target $14
MAXM
Buy
Viking Therapeutics price target raised to $14 from $8 at Maxim
Maxim analyst Jason McCarthy raised his price target for Viking Therapeutics (VKTX) to $14 from $8 saying the data yesterday from Madrigal Pharmaceuticals (MDGL) suggests that this class of Thyroid Hormone Receptor Beta agonist may be a successful treatment for NASH and that Viking's VK2809 could have similar success.
06/01/18
ROTH
06/01/18
NO CHANGE
Target $13
ROTH
Buy
Viking Therapeutics price target raised to $13 from $7.50 at Roth Capital
Roth Capital analyst Scott Henry maintained a Buy rating on Viking Therapeutics while raising his price target to $13 from $7.50 saying the data yesterday from Madrigal Pharmaceuticals (MDGL) appears to validate the class of Thyroid Hormone Receptor Beta agonist compounds, noting that Viking's VK2809 is a similar agonist. In a research note to investors, Henry said he assumes that enrollment for VK2809 in a Phase 2 trial to treat NAFLD/hypercholesterolemia will be completed this month with a data readout in about October, and, assuming the readout is positive, Viking will meet with the FDA to determine the next steps. Henry believes the company may look to move directly to a phase 2/3 sequential trial.
06/05/18
MAXM
06/05/18
NO CHANGE
Target $14
MAXM
Buy
Chances of beta agonist success favors Viking Therapeutics, says Maxim
After Viking Therapeutics (VKTX) announced that enrollment has been completed in the company's ongoing Phase 2 clinical trial of VK2809 in patients with primary hypercholesterolemia and non-alcoholic fatty liver disease, Maxim analyst Jason McCarthy said that given Viking's prior data and the data for Madrigal's (MDGL) MGL-3196, which is in the same class of Thyroid Hormone Receptor beta agonists, that he believes the probability of success favors Viking. He maintains a Buy rating and $14 price target on Viking shares.
MDGL Madrigal Pharmaceuticals
$313.25

31.25 (11.08%)

06/07/18
EVER
06/07/18
NO CHANGE
Target $300
EVER
Outperform
Evercore ISI 'comfortable' with $300 price target on Madrigal after secondary
Evercore ISI analyst Josh Schimmer said he remains "comfortable" with his $300 price target on Madrigal Pharmaceuticals despite the stock trading off following the company's secondary offering of stock. After fielding calls from investors, Schimmer thinks a lack of catalysts "is probably the number one concern," as the company hopes to be able to start a Phase 3 NASH trial by year-end, which "probably means a 2-3 year void of news flow." Schimmer also listed long-term safety and efficacy and competitive dynamics as concerns voiced by investors he spoke with. He maintains an Outperform rating on Madrigal, which dropped over 10% in today's trading to about $281 per share.
06/12/18
MAXM
06/12/18
NO CHANGE
Target $30
MAXM
Buy
Galmed price target raised to $30 from $14 at Maxim
Maxim analyst Jason McCarthy raised his outyear estimates for Aramchol and reduced his risk adjustment to 15% from 30% following the announcement of Galmed's (GLMD) Phase 2b data for Aramchol in NASH. Given the changes, he raised his price target on Galmed shares to $30 from $14, which he notes implies a market capitalization of $450M. That valuation may be viewed as "conservative" given the rise in valuations of others in the NASH space, including Madrigal (MDGL), which McCarthy said completed a Phase 2 study that was "smaller and shorter" than Galmed. He maintains a Buy rating on Galmed shares, which are up $13, or 185% to about $20 per share in afternoon trading.

TODAY'S FREE FLY STORIES

LTS

Ladenburg Thalmann

$2.79

-0.01 (-0.36%)

11:06
09/18/18
09/18
11:06
09/18/18
11:06
Periodicals
Ladenburg Thalmann mentioned cautiously by Seeking Alpha contributor »

A contributor to Seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

USB

U.S. Bancorp

$54.15

0.01 (0.02%)

11:05
09/18/18
09/18
11:05
09/18/18
11:05
Hot Stocks
U.S. Bancorp announces 23% increase in quarterly dividend to 37c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TLRY

Tilray

$141.50

21.3 (17.72%)

, CRON

Cronos Group

$11.43

1.25 (12.28%)

11:04
09/18/18
09/18
11:04
09/18/18
11:04
Hot Stocks
Cannabis stocks in focus after Tilray gets DEA approval to import cannabis drug »

Shares of cannabis stocks…

TLRY

Tilray

$141.50

21.3 (17.72%)

CRON

Cronos Group

$11.43

1.25 (12.28%)

KO

Coca-Cola

$46.14

-0.18 (-0.39%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$50.36

1.84 (3.79%)

CBIS

Cannabis Science

$0.00

(0.00%)

IIPR

Innovative Industrial Properties

$44.09

1.12 (2.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Oct

P

Pandora

$9.70

0.21 (2.21%)

, SPOT

Spotify

$178.02

3.37 (1.93%)

11:01
09/18/18
09/18
11:01
09/18/18
11:01
Hot Stocks
Appeals court upholds Copyright Royalty Board rate determination »

SoundExchange challenged…

P

Pandora

$9.70

0.21 (2.21%)

SPOT

Spotify

$178.02

3.37 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDU

New Oriental Education

$67.99

-0.81 (-1.18%)

11:00
09/18/18
09/18
11:00
09/18/18
11:00
Options
Far upside call buyer in New Oriental Education and Technology Group »

Far upside call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
09/18/18
09/18
11:00
09/18/18
11:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

10:55
09/18/18
09/18
10:55
09/18/18
10:55
Conference/Events
Morgan Stanley healthcare/pharma analysts hold analyst/industry conference call »

Pharmaceuticals Analyst…

WM

Waste Management

$92.35

0.22 (0.24%)

10:55
09/18/18
09/18
10:55
09/18/18
10:55
Conference/Events
Waste Management has conference call hosted by UBS »

UBS Technology Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

ATHN

Athenahealth

$134.93

-8.325 (-5.81%)

10:50
09/18/18
09/18
10:50
09/18/18
10:50
Periodicals
Kosman says 'not true' that Post was wrong on Athenahealth »

Josh Kosman, one of two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETE

Energy Transfer Equity

$17.38

0.07 (0.40%)

10:50
09/18/18
09/18
10:50
09/18/18
10:50
Options
Heavy bullish call volume in Energy Transfer Equity »

Heavy bullish call volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$160.67

0.07 (0.04%)

10:46
09/18/18
09/18
10:46
09/18/18
10:46
Periodicals
Facebook named in job ad discrimination lawsuit, TechCrunch reports »

Facebook has been named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

DLTR

Dollar Tree

$84.87

-0.63 (-0.74%)

10:40
09/18/18
09/18
10:40
09/18/18
10:40
Options
Dollar Tree draws bullish option flow »

Dollar Tree draws bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 10

    Oct

WMT

Walmart

$94.92

0.09 (0.09%)

, TGT

Target

$87.72

0.45 (0.52%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

WMT

Walmart

$94.92

0.09 (0.09%)

TGT

Target

$87.72

0.45 (0.52%)

APA

Apache

$46.69

0.91 (1.99%)

SUPN

Supernus

$47.80

1.85 (4.03%)

RIG

Transocean

$11.93

0.335 (2.89%)

NE

Noble Corp.

$6.21

0.25 (4.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

  • 01

    Oct

  • 28

    Oct

  • 15

    Nov

  • 27

    Nov

  • 03

    Mar

FTNT

Fortinet

$88.88

0.69 (0.78%)

, UAL

United Continental

$89.26

-0.89 (-0.99%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

FTNT

Fortinet

$88.88

0.69 (0.78%)

UAL

United Continental

$89.26

-0.89 (-0.99%)

WK

Workiva

$33.15

-4.65 (-12.30%)

DISCA

Discovery

$31.60

-0.41 (-1.28%)

APA

Apache

$46.69

0.91 (1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Dec

  • 10

    Dec

CTSH

Cognizant

$76.97

1.02 (1.34%)

, CASY

Casey's General Stores

$127.78

2.48 (1.98%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

CTSH

Cognizant

$76.97

1.02 (1.34%)

CASY

Casey's General Stores

$127.78

2.48 (1.98%)

OXY

Occidental Petroleum

$79.88

2.26 (2.91%)

VALE

Vale

$13.63

0.275 (2.06%)

TRGP

Targa Resources

$56.50

1.85 (3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Oct

  • 06

    Nov

  • 16

    Nov

PBR

Petrobras

$11.04

0.115 (1.05%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30
Options
Second day of size option block in Petrobras »

Second day of size option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$49.53

3.1 (6.68%)

, GOOG

Alphabet

$1,163.16

6.78 (0.59%)

10:26
09/18/18
09/18
10:26
09/18/18
10:26
Hot Stocks
Nutanix rises after analysts call selloff 'excessive', 'overblown' »

Shares of cloud computing…

NTNX

Nutanix

$49.53

3.1 (6.68%)

GOOG

Alphabet

$1,163.16

6.78 (0.59%)

GOOGL

Alphabet Class A

$1,166.89

7.56 (0.65%)

MSFT

Microsoft

$113.20

1.01 (0.90%)

VMW

VMware

$158.30

1.3 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts…

JAZZ

Jazz Pharmaceuticals

$160.31

-0.66 (-0.41%)

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
Jazz Pharmaceuticals to hold an informational webcast »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 27

    Oct

  • 27

    Nov

  • 20

    Dec

BWA

BorgWarner

$42.29

-1.87 (-4.23%)

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
BorgWarner to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Oct

10:25
09/18/18
09/18
10:25
09/18/18
10:25
Conference/Events
Citigroup Healthcare IT analysts to an hold analyst/industry conference call »

Healthcare IT Analysts…

ATHN

Athenahealth

$134.10

-9.155 (-6.39%)

10:22
09/18/18
09/18
10:22
09/18/18
10:22
Hot Stocks
Athenahealth drops after Elliott said to pull back from $160 per share bid »

Shares of Athenahealth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$5.73

0.28 (5.14%)

10:20
09/18/18
09/18
10:20
09/18/18
10:20
Options
Flurry of activity in FitBit calls as shares see strength »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$94.85

0.02 (0.02%)

10:17
09/18/18
09/18
10:17
09/18/18
10:17
Periodicals
Bonobos co-founder and CEO Andy Dunn steps down, Inc reports »

Bonobos's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/18/18
09/18
10:17
09/18/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.